ATLASFoghorn Therapeutics (FHTX) earnings date: Nov 4, 2026
Foghorn Therapeutics (FHTX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of -$0.23.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on FHTX
| Last price | $2.08 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.7% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Foghorn Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Foghorn Therapeutics reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Foghorn Therapeutics. You can switch it off at any time.
Alert me before FHTX reportsFree to start. Creating an account takes under a minute.
FHTX earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.23 |
| Last report | Oct 13, 2026 · Beat |
| Beat rate (last 6 reports) | 5 of 6 (83%) |
| Average EPS surprise | +12.3% |
| Average move around a report | ±9.8% (last 6) |
| Sector | Healthcare · Biotechnology |
Foghorn Therapeutics earnings history: last 6 reports
Foghorn Therapeutics last reported on Oct 13, 2026: EPS of $17.01 against an estimate of $13.09 (+30.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 13, 2026 | $13.09 | $17.01 | +30.0% | Beat | -5.1% |
| Aug 6, 2026 | -$0.23 | -$0.10 | +56.5% | Beat | +24.4% |
| May 7, 2026 | -$0.31 | -$0.29 | +6.5% | Beat | -5.1% |
| Mar 11, 2026 | -$0.26 | -$0.37 | -42.3% | Miss | -10.4% |
| Nov 5, 2025 | -$0.30 | -$0.25 | +16.7% | Beat | +13.3% |
| Oct 21, 2025 | $2.10 | $2.24 | +6.7% | Beat | -0.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for FHTX
See the fair value, the probability range and the earnings history of Foghorn Therapeutics on its ATLAS page.
Foghorn Therapeutics (FHTX) stock analysisPlans from €3.99 a month.
Foghorn Therapeutics earnings: frequently asked questions
When does Foghorn Therapeutics (FHTX) report earnings?
Foghorn Therapeutics is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for FHTX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.23 per share (USD). Estimates can change before the report.
How often does FHTX beat earnings estimates?
Of its last 6 reports with a recorded result, Foghorn Therapeutics beat the EPS estimate 5 times; the average surprise was +12.3%. Past results do not predict the next one.
How much does FHTX move around earnings?
Over its last 6 reports the stock moved an average of 9.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 6 times.
Did Foghorn Therapeutics beat earnings estimates last quarter?
Foghorn Therapeutics last reported on Oct 13, 2026: EPS of $17.01 against an estimate of $13.09 (+30.0% surprise), a beat.
How much does FHTX usually move in a day?
On a normal trading day the ATLAS model puts FHTX’s one-day range at about ±5.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer